A phase I study of imexon in combination with docetaxel (DOC) for the treatment of patients with breast, lung and prostate cancer
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: S. L. Moulder, N. Dhillon, D. S. Hong, C. S. Ng, L. H. Camacho, E. M. Hersh, K. A. Grenier, M. L. Boytim, R. T. Dorr, R. Kurzrock
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2244785344
